Educational Overview Peptides and Brain Health: What the Research Shows Published 10/6/2026 Traumatic brain injury (TBI), repeated head impacts such as those linked to chronic traumatic encephalopathy (CTE), and age-related memory and thinking changes are among the hardest problems in medicine. Researchers have been exploring a number of peptides in this area, including Semax, Selank, […]
Educational Overview Thymosin Alpha-1: What the Research Shows Originally published 9/3/2024 · Updated 10/6/2026 Thymosin alpha-1 (also called thymalfasin or TA-1) is a peptide first identified in extracts of the thymus gland, an organ involved in the development of T-cells. It has been studied in laboratories and clinical trials for decades. This article is a […]
Educational Overview Low-Dose Naltrexone (LDN): What the Research Shows Originally published 8/14/2024 · Updated 10/6/2026 Naltrexone is a long-established medication. Researchers have also been studying it at doses far lower than the standard one, an approach commonly called low-dose naltrexone, or LDN. This article offers a general introduction: what LDN is, how scientists think it […]
Educational Overview Ipamorelin vs. Tesamorelin: What the Research Shows Originally published 3/29/2024 · Updated 10/6/2026 Ipamorelin and tesamorelin are often mentioned together because both relate to growth hormone signaling. They are different molecules, studied in different ways, and with very different regulatory standing. This article explains how they differ, what clinical research has examined, and […]
Educational Overview Peptide Therapy: What It Is and What the Research Shows Originally published 1/12/2024 · Updated 10/6/2026 Peptides are short chains of amino acids, and “peptide therapy” has become a popular phrase. But it covers very different things: a few FDA-approved medicines with labeled uses and warnings, and many other compounds marketed without FDA […]